Pfizer withdraws all lots of sickle cell disease treatment voxelotor
Pfizer's decision is based on the totality of clinical data
Pfizer's decision is based on the totality of clinical data
Funding to support clinical development, gene therapy pipeline expansion and GMP manufacturing capabilities
Subscribe To Our Newsletter & Stay Updated